Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NMTC

NMTC - NeuroOne Medical Technologies Corp Stock Price, Fair Value and News

$0.91+0.01 (+1.11%)
Market Closed

44/100

NMTC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

44/100

NMTC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.79

Target 3M

$0.84

Target 6M

$0.82

NMTC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NMTC Price Action

Last 7 days

1.1%

Last 30 days

26.4%

Last 90 days

15.2%

Trailing 12 Months

-20.9%

NMTC RSI Chart

NMTC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NMTC Valuation

Market Cap

43.4M

Price/Earnings (Trailing)

-12.03

Price/Sales (Trailing)

14.45

EV/EBITDA

-11

Price/Free Cashflow

-14.85

NMTC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.79

Target 3M

$0.84

Target 6M

$0.82

NMTC Fundamentals

NMTC Revenue

Revenue (TTM)

3.0M

Rev. Growth (Yr)

-100%

NMTC Earnings

Earnings (TTM)

-3.6M

Earnings Growth (Yr)

51.67%

Earnings Growth (Qtr)

-7.89%

NMTC Profitability

Operating Margin

-31.88%

EBT Margin

-120.18%

Return on Equity

-50.98%

Return on Assets

-33.43%

Free Cashflow Yield

-6.73%

NMTC Investor Care

Shares Dilution (1Y)

63.46%

Diluted EPS (TTM)

-0.08

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20253.2M3.1M3.0M0
2024003.5M3.3M
2023813.2K1.1M1.5M0
202228.8K100.0K171.2K492.2K
20211.0M567.2K114.0K48.9K
2020001.9M1.5M
20141.6M000
2013331.1K650.2K969.3K1.3M
201200012.0K
20110005.4K
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About NeuroOne Medical Technologies Corp

NMTC
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
 CEO
 WEBSITEn1mtc.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES15

NeuroOne Medical Technologies Corp Frequently Asked Questions

NMTC is the stock ticker symbol of NeuroOne Medical Technologies Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of NeuroOne Medical Technologies Corp is 43.36 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NMTC's fair value in chart for subscribers.

The fair value guage provides a quick view whether NMTC is over valued or under valued. Whether NeuroOne Medical Technologies Corp is cheap or expensive depends on the assumptions which impact NeuroOne Medical Technologies Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NMTC.

As of Wed Jan 28 2026, NMTC's PE ratio (Price to Earnings) is -12.03 and Price to Sales (PS) ratio is 14.45. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NMTC PE ratio will change depending on the future growth rate expectations of investors.